Sunil Pai Dayananda

Sunil Pai Dayananda

Active Director Managing Director DIN 06364636
DIN 06364636 First appointment Nov 2012 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 1 historical roles
Total affiliations 2 Since Nov 2012
Shareholding value •••• Premium profile

About Sunil Pai Dayananda

Data last updated:

Sunil Pai Dayananda has 13 years in corporate governance. Holds Managing Director and Director roles. Currently with 1 company, including Futura Therapeutics Private Limited and Renos Pharma Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Renos Pharma Private Limited at ₹3.39 Cr (FY 2024).

DIN 06364636
Primary Designation Managing Director
First Appointment 02 Nov 2012
Oldest Company Age 13 yrs
Largest company Renos Pharma Private Limited · ₹3.39 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Renos Pharma Private Limited U51397KL2016PTC040395
Director16 May 20162016₹3.39 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Futura Therapeutics Private Limited U51397KL2012PTC032528
Managing Director02 Nov 20122012–Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Futura Therapeutics Private Limited
Renos Pharma Private Limited
Premium access

Shareholding and investment profile for Sunil Pai Dayananda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Pai Dayananda

Sunil Pai Dayananda has 13 years in corporate governance. Holds Managing Director and Director roles. Currently with 1 company, including Futura Therapeutics Private Limited and Renos Pharma Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Renos Pharma Private Limited at ₹3.39 Cr (FY 2024).

Sunil Pai Dayananda is associated with 1 company as Managing Director and Director, including Renos Pharma Private Limited (₹3.39 Cr).

Sunil Pai Dayananda has expertise in General Business.

Sunil Pai Dayananda has 13 years in corporate governance.

By reported revenue, the largest current company of Sunil Pai Dayananda is Renos Pharma Private Limited, with revenue of ₹3.39 Cr (FY 2024).

Sunil Pai Dayananda currently holds positions at 1 company: Renos Pharma Private Limited (₹3.39 Cr).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available